ak 295 has been researched along with calpastatin in 1 studies
Studies (ak 295) | Trials (ak 295) | Recent Studies (post-2010) (ak 295) | Studies (calpastatin) | Trials (calpastatin) | Recent Studies (post-2010) (calpastatin) |
---|---|---|---|---|---|
13 | 0 | 0 | 998 | 5 | 250 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, AL; Bahr, BA; Blomgren, K; Hagberg, H; Hallin, U; Kawashima, S; McRae, A; Puka-Sundvall, M; Saido, TC | 1 |
1 other study(ies) available for ak 295 and calpastatin
Article | Year |
---|---|
Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Calcium-Binding Proteins; Calpain; Cell Membrane; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Female; Functional Laterality; Hypoxia; Male; Rats; Rats, Wistar; Up-Regulation | 1999 |